Literature DB >> 3383377

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

B I Levy1, J B Michel, J L Salzmann, M Azizi, P Poitevin, M Safar, J P Camilleri.   

Abstract

The effect of hypertension and of therapy by converting enzyme inhibitor (S 9490-3, perindopril) on the function and structure of large arteries has been studied in two-kidney, one-clip Goldblatt hypertensive rats. After one month without treatment, clipped hypertensive rats (n = 24) and sham-operated rats (n = 24) were randomly allocated to treatment by S 9490, 1 mg/kg once a day (n = 24) or to placebo (n = 24) and pursued for 4 weeks. Hemodynamic parameters, including instantaneous pressure and aortic velocity measured by Döppler, were recorded under anesthesia at the end of the treatment period. Passive mechanical properties of carotid arteries were recorded in situ in the presence or the absence of smooth muscle cell activity (potassium cyanide poisoning). Morphological parameters of the aortic media, including medial thickness, nucleus density, and cross sectional area and relative density in proteins of interstitial matrix, were recorded by an automated morphometrical system. Hypertension was associated with an increase in characteristic impedance of the aorta and a decrease in compliance of the arterial system. Treatment with converting enzyme inhibitors completely reversed these in vivo markers of the rigidity of large arteries. Hypertension was associated with a shift of the passive pressure-volume relation in the carotid. Treatment with converting enzyme inhibitors normalized the carotid pressure-volume relation, whereas poisoning smooth muscle cells induced a disappearance of the curve differences between hypertensive and normotensive animals. Morphometric analysis of aortic walls permits us to report this functional change to structural modification of the arterial wall. Aortic media thickness was increased by hypertension; this phenomenon was reversed by treatment. Modification of aortic thickness was due to hypertrophy of smooth muscle cells with parallel modifications of absolute amount of collagen, whereas absolute amount of elastin did not change in this early phase of renovascular hypertension in young rats. Treatment with converting enzyme inhibitors reversed the thickness of aortic media without regression of the increase in absolute amount of collagen content whereas absolute amount of elastin content did not change.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383377     DOI: 10.1161/01.res.63.1.227

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  24 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Arterial aging--hemodynamic changes and therapeutic options.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

Review 3.  Ageing and its effects on the cardiovascular system.

Authors:  M Safar
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.

Authors:  Amanda Soler; Ian Hunter; Gregory Joseph; Rebecca Hutcheson; Brenda Hutcheson; Jenny Yang; Frank Fan Zhang; Sachindra Raj Joshi; Chastity Bradford; Katherine H Gotlinger; Rachana Maniyar; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Sachin A Gupte; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2018-02-08       Impact factor: 5.000

Review 5.  ACE inhibitors in acute and chronic ischaemia: current status and future promise.

Authors:  E H Sonnenblick; M Zhao; C Eng; T H LeJemtel; S M Factor; J Capasso; P Anversa
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 6.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

7.  Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells.

Authors:  Chien-Hung Huang; Jin-Shuei Ciou; Shun-Tsung Chen; Victor C Kok; Yi Chung; Jeffrey J P Tsai; Nilubon Kurubanjerdjit; Chi-Ying F Huang; Ka-Lok Ng
Journal:  PeerJ       Date:  2016-09-28       Impact factor: 2.984

Review 8.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 9.  Peripheral factors in the management of congestive heart failure.

Authors:  L Demopoulos; T H LeJemtel
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.

Authors:  R Morishita; G H Gibbons; K E Ellison; W Lee; L Zhang; H Yu; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.